Lululemon Athletica (LULU) Earnings Analysis

Lululemon Athletica (LULU) delivered mixed results in FY2026 on revenue of $42.8B versus the $43.0B estimate (+0.8% YoY) and EPS of $3.21. Below is the full Lululemon Athletica earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Lululemon Athletica (LULU) Earnings Analysis — key stats

Latest reported quarterFY2026
Earnings verdictMixed
Revenue$42.8B (vs $43.0B est · -0.5% surprise · +0.8% YoY)
EPS$3.21 (vs $3.04 est · +5.6% surprise · -11.7% YoY)
Share price$305.29 (-3.3%)
Market cap$610.0B

What you'll find

Frequently asked questions

When is Lululemon Athletica's next earnings date?
Magnisto tracks Lululemon Athletica's (LULU) earnings schedule and shows the confirmed next earnings date, the options-implied expected move and the estimates analysts are modeling into the print.
Did Lululemon Athletica (LULU) beat or miss earnings?
In FY2026, Lululemon Athletica (LULU) posted mixed results — revenue of $42.8B versus the $43.0B estimate (-0.5% surprise) and EPS of $3.21 versus $3.04 expected (+5.6% surprise). Magnisto decodes every Lululemon Athletica (LULU) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Lululemon Athletica (LULU) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Lululemon Athletica (LULU), anchored to the current $305.29 share price, so you can weigh the bull, base and bear cases for Lululemon Athletica side by side.
Is Lululemon Athletica (LULU) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Lululemon Athletica fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.